Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:45:21.149Z.
Calculation as of: 2026-10-06T14:45:21.149Z.
Quote observation: 2026-10-06T14:45:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f621ea2a381ac0066d385c57ed104ff22630177ee14cd635e65ed0429d7856c2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$551.88M
EV/EBIT Ratio
N/A
TTM Avg
14.25x
3Y Avg
18.01x
5Y Avg
18.01x
Market Cap
$558.79M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$563.97M
EV/EBIT Ratio
N/A
TTM Avg
78.65x
3Y Avg
78.65x
5Y Avg
78.65x
Market Cap
$533.42M
EV/EBIT Ratio
N/A
TTM Avg
189.50x
3Y Avg
189.50x
5Y Avg
189.50x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $549.58M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $551.88M | N/A | 14.25x | 18.01x | 18.01x |
| Nuvectis Pharma, Inc. (NVCT)vs › | $545.32M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $558.79M | N/A | N/A | N/A | N/A |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $563.97M | N/A | 78.65x | 78.65x | 78.65x |
| CorMedix Inc. (CRMD)vs › | $562.50M | 2.08x | 6.25x | 15.98x | 15.98x |
| Delcath Systems, Inc. (DCTH)vs › | $533.42M | N/A | 189.50x | 189.50x | 189.50x |
| ArriVent BioPharma, Inc. (AVBP)vs › | $580.32M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $523.36M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
